Evotec

Maximize omics data interpretation by centralizing your data storage and leveraging the power of PanHunter! Dedicated module guides you through uploading your sample table and abundance data via user-friendly interface. We support raw count matrices from transcriptomics and protein intensity matrices from proteomics. Omics data should not be stored in silos! Learn how to easily upload your transcriptomics and proteomics datasets today: https://hubs.ly/Q02HfyLw0 #researchneverstops #panhunter #omics #transcriptomics #proteomics #dataanalysis #datascience

We are continuing our webinar series on hit identification strategies at Evotec. Please register now for episode 4 "The Role of Structural Insights in Drug Discovery". Join as as Dr. Jay Bertrand, Vice President, Head of Global Structural Biology and Evotec's Princeton Site Head, discusses the evolution of structural support to drug discovery projects, and provides insight into choosing the right protein for structural analysis. He will also share case studies on the application of X-ray and cryo-EM to obtain compound-bound protein structures. https://hubs.ly/Q02H5-QK0

Associate Professor Lena Ho from Duke-NUS Medical School has been awarded US$1.85 million (approx. S$2.51 million) to further her team’s research in developing microproteins into therapeutic targets to treat chronic inflammation. She is the first scientist to receive funding from 65LAB, a unique partnership set up to drive scientific advancement and create new biotech ventures from Singapore. The award comprises US$ 1.5 million from 65LAB, and US$350,000 from Duke-NUS’ new incubator, LIVE Ventures. To learn more, read the press release here-https://hubs.ly/Q02Jbpfv0 #ResearchNeverStops #TogetherForMedicinesThatMatter Duke-NUS Medical School ClavystBio Leaps by Bayer Lightstone Ventures Polaris Partners Polaris Innovation Fund

Missed our live webinars on “Mastering Quality by Design”? Catch up on-demand! Evotec’s Quality by Design webinar series is now available to stream on-demand. Dive into the sessions at your convenience and gain valuable insights into QbD’s role in enhancing pharmaceutical quality. https://hubs.ly/Q02Hsm2T0. #drugdevelopment #QualityByDesign

In the quest to revolutionize immunotherapy, the identification of naturally presented peptides bound to HLA class I and II molecules from cancerous cells holds paramount importance. Evotec’s pioneering immunopeptidomics platform stands at the forefront, enabling the unbiased discovery of novel immunotherapeutic targets. Learn more about Evotec’s immunopeptidomics platform in our latest blog, Advancing Immunotherapy through Immunopeptidome Deciphering for Neoantigen Identification. https://hubs.ly/Q02H5HSv0

Evotec Machine Learning Scientist wins "Biomarker of Aging Challenge" Age-related disease is an important therapeutic area for Evotec. Our aim is slow down age-related diseases allowing people to maintain a high quality of life throughout their later decades. Understanding these natural patterns and signatures of ageing helps us identify novel targets / biomarkers plus support work with our partners. In Evotec Bioinformatics we apply machine learning algorithms to high-dimensional omics data, e.g. to predict compound toxicity or to find disease biomarkers. Hence, we got excited when the Biomarkers of Aging Consortium together with the Methuselah Foundation and the VoLo Foundation created the Biomarkers of Aging Challenge. In this challenge, scientists from many excellent research institutions across the world compete for the best models to predict chronological age, mortality, and multi-morbidity. In collaboration with disease experts from the In Vitro Biology department, ML Scientist Julian Reinhard developed a deep learning model predicting chronological age based on methylation data provided by the consortium. It was a tight race, but now the results for the first phase of the challenge are in: Julian won the 1st place with a final score of 2.45 year age error! Congratulations to Julian! https://hubs.ly/Q02HXg0c0 #researchneverstops #biomarker

David Pardoe, SVP and Head of Global Molecular Architects at Evotec, lays out the stark challenges for drug discovery, and the urgent response that AI can help to drive in a recent discussion with GT life science, "Now is the time that we DO need automation...to harvest all of that information and data - largely unstructured - to put it into a form that we can easily exploit and explore, and to help us make those really difficult in drug discovery and development." Check out the video here- https://hubs.ly/Q02H5-S10?

Curious to learn about hit identification and high throughput screening strategies at Evotec? Join our 5-part webinar series now. The first 3 episodes are already available on demand, while new episodes in September and October are open for registration now. Overview of the episodes: #1: Unlocking High Throughput Hit Identification Strategies, with Thomas Ahrens #2: It All Starts With a Protein – Protein Sciences as a Key to Success in Drug Discovery, with James Errey #3: Molecular Interactions Matter - Biophysical Screening for Early Drug Discovery, with Florian Krieger #4: The Role of Structural Insights in Drug Discovery, with Jay Bertrand #5: Illuminating Cellular Processes through High Content Methods, with Karsten Kottig and Sven Schreiter To find more information, and to get access to the individual sessions, please visit: https://hubs.ly/Q02H5HRr0 #researchneverstops #Evotec #drugdiscovery

The new ICH M12 Guideline for drug-drug interaction studies is out. Here is everything you need to learn about the latest changes and the best practices to stay compliant. Read here- https://hubs.ly/Q02HqW7c0 For further enquiries, contact us at enquiries@cyprotex.com

As the world increasingly focuses on sustainability, the pharmaceutical and biotech industry is following suit. Evotec is not just setting the benchmark for sustainability in drug discovery; we are proving that excellence in medicinal chemistry and environmental stewardship can go hand in hand. As we continue to innovate and implement green practices, Evotec is paving the way for a more sustainable future in pharmaceuticals. Read more about Evotec’s green chemistry initiatives and their impact on the pharmaceutical industry in our latest blog post! https://hubs.ly/Q02H5RHm0 #researchneverstops #Sustainability #GreenChemistry